|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$1,927,240
|
N/A
|
National Institutes of Health
|
|
NATIONAL FOOD AND NUTRIENT ANALYSIS PROGRAM (NFNAP) DIETARY NUTRIENTS
|
ACN18004-001
|
$225,000
|
$22,500
|
-, -
|
UNITED STATES DEPT OF AGRICULTURE
|
|
Novel platform linking cancer-specific glycosylation with cell signaling outcomes
|
1R21CA229044-01
|
$225,250
|
$112,625
|
ABBOTT, KAREN
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Glycomics Laboratory for the Development of Ovarian Cancer Biomarkers
|
1U01CA226055-01
|
$768,101
|
$768,101
|
ABBOTT, KAREN
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Detection of somatic, subclonal and mosaic CNVs from sequencing
|
1U24CA220242-01A1
|
$559,916
|
$279,958
|
ABYZOV, ALEXEJ
|
MAYO CLINIC ROCHESTER
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-03
|
$215,047
|
$107,524
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
|
5R01CA211648-02
|
$432,788
|
$432,788
|
ADLI, MAZHAR
|
UNIVERSITY OF VIRGINIA
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
5U54CA163069-08
|
$1,347,488
|
$67,374
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-04S1
|
$145,357
|
$2,907
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-05
|
$922,200
|
$18,444
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer
|
5R00CA194309-04
|
$210,465
|
$210,465
|
AIRD, KATHERINE
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-05
|
$1,223,634
|
$24,473
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
|
5U01CA202144-04
|
$741,952
|
$370,976
|
ALTER, ORLY
|
UNIVERSITY OF UTAH
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S1
|
$142,498
|
$18,525
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S2
|
$200,000
|
$26,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
$343,926
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
$28,090
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Nuclear Factor-kappaB in Ovarian Cancer
|
ZIA BC 011054
|
$480,705
|
$480,705
|
Annunziata, Christina
|
CCR (NCI)
|
|
Clinical trials in women's cancers
|
ZIA BC 011584
|
$192,282
|
$134,597
|
Annunziata, Christina
|
CCR (NCI)
|
|
Immune cell control of ovarian cancer
|
ZIA BC 011775
|
$288,423
|
$288,423
|
Annunziata, Christina
|
CCR (NCI)
|
|
Protease activated receptor-2 (PAR-2) signaling and metastatic ovarian cancer
|
5R01CA196988-02
|
$353,419
|
$353,419
|
ANTALIS, TONI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-05
|
$605,293
|
$30,265
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
|
ZIA BC 011197
|
$583,055
|
$291,527
|
Appella, Ettore
|
CCR (NCI)
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
$2,485
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
$1,715
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
$33,345
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$79,544
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$840
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$2,065
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$2,578
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$183,605
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$10,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$5,449
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$3,028
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$1,271
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
FOXM1-RHNO1 Oncogenic Axis in Ovarian Cancer
|
4K00CA212470-03
|
$71,280
|
$71,280
|
BARGER, CARTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the Major Histocompatibility Class I-LILRB1 signaling axis for cancer immunotherapy by macrophages
|
1F30CA232472-01
|
$43,039
|
$21,520
|
BARKAL, AMIRA
|
STANFORD UNIVERSITY
|
|
Inflammation and gynecologic cancer: the role of prostaglandins in ovarian cancer
|
4K00CA212222-03
|
$88,280
|
$88,280
|
BARNARD, MOLLIE
|
UNIVERSITY OF UTAH
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$30,758
|
Barr, Frederic
|
CCR (NCI)
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-05
|
$1,394,352
|
$104,576
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Molecular and Imaging Assessment of Fallopian Tube Health
|
1R21CA229707-01
|
$188,966
|
$188,966
|
BARTON, JENNIFER
|
UNIVERSITY OF ARIZONA
|
|
Early detection of ovarian cancer by serum marker and targeted ultrasound imaging
|
5R01CA210370-03
|
$356,233
|
$356,233
|
BARUA, ANIMESH
|
RUSH UNIVERSITY MEDICAL CENTER
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
$1,813,624
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
|
5R01CA135354-08
|
$380,000
|
$380,000
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer
|
5U01CA200462-03
|
$910,580
|
$910,580
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Regulation of RNA biogenesis and function by RNA modifications
|
ZIA BC 011766
|
$1,075,766
|
$376,518
|
Batista, Pedro
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA042014-29S1
|
$125,000
|
$7,500
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S2
|
$250,000
|
$15,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S3
|
$248,625
|
$14,918
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
Total relevant funding to Ovarian Cancer for this search: $120,788,374
|